153 related articles for article (PubMed ID: 35616366)
21. Cholesterol 7α-hydroxylase protects the liver from inflammation and fibrosis by maintaining cholesterol homeostasis.
Liu H; Pathak P; Boehme S; Chiang JL
J Lipid Res; 2016 Oct; 57(10):1831-1844. PubMed ID: 27534992
[TBL] [Abstract][Full Text] [Related]
22. Removal of the bile acid pool upregulates cholesterol 7alpha-hydroxylase by deactivating FXR in rabbits.
Xu G; Pan LX; Erickson SK; Forman BM; Shneider BL; Ananthanarayanan M; Li X; Shefer S; Balasubramanian N; Ma L; Asaoka H; Lear SR; Nguyen LB; Dussault I; Suchy FJ; Tint GS; Salen G
J Lipid Res; 2002 Jan; 43(1):45-50. PubMed ID: 11792721
[TBL] [Abstract][Full Text] [Related]
23. Farnesoid X Receptor Activation Enhances Transforming Growth Factor β-Induced Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells.
Kainuma M; Takada I; Makishima M; Sano K
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29958417
[TBL] [Abstract][Full Text] [Related]
24. Novel ι-Carrageenan Tetrasaccharide Alleviates Liver Lipid Accumulation via the Bile Acid-FXR-SHP/PXR Pathway to Regulate Cholesterol Conversion and Fatty Acid Metabolism in Insulin-Resistant Mice.
Li Y; Tian Y; Cai W; Wang Q; Chang Y; Sun Y; Dong P; Wang J
J Agric Food Chem; 2021 Sep; 69(34):9813-9821. PubMed ID: 34415766
[TBL] [Abstract][Full Text] [Related]
25. Lycium barbarum L. Balanced intestinal flora with YAP1/FXR activation in drug-induced liver injury.
Lu J; Gao Y; Gong Y; Yue Y; Yang Y; Xiong Y; Zhang Y; Xiao Y; Wang H; Fan H; Shi X
Int Immunopharmacol; 2024 Mar; 130():111762. PubMed ID: 38428146
[TBL] [Abstract][Full Text] [Related]
26. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist.
Sayin SI; Wahlström A; Felin J; Jäntti S; Marschall HU; Bamberg K; Angelin B; Hyötyläinen T; Orešič M; Bäckhed F
Cell Metab; 2013 Feb; 17(2):225-35. PubMed ID: 23395169
[TBL] [Abstract][Full Text] [Related]
27. Differential regulation of bile acid and cholesterol metabolism by the farnesoid X receptor in Ldlr -/- mice versus hamsters.
Gardès C; Chaput E; Staempfli A; Blum D; Richter H; Benson GM
J Lipid Res; 2013 May; 54(5):1283-99. PubMed ID: 23431047
[TBL] [Abstract][Full Text] [Related]
28. Preliminary experimental research on the mechanism of liver bile secretion stimulated by peppermint oil.
Zong L; Qu Y; Luo DX; Zhu ZY; Zhang S; Su Z; Shan JC; Gao XP; Lu LG
J Dig Dis; 2011 Aug; 12(4):295-301. PubMed ID: 21791024
[TBL] [Abstract][Full Text] [Related]
29. Dihydroartemisinin counteracts fibrotic portal hypertension via farnesoid X receptor-dependent inhibition of hepatic stellate cell contraction.
Xu W; Lu C; Zhang F; Shao J; Yao S; Zheng S
FEBS J; 2017 Jan; 284(1):114-133. PubMed ID: 27896916
[TBL] [Abstract][Full Text] [Related]
30. SIX4 promotes hepatocellular carcinoma metastasis through upregulating YAP1 and c-MET.
He Q; Lin Z; Wang Z; Huang W; Tian D; Liu M; Xia L
Oncogene; 2020 Dec; 39(50):7279-7295. PubMed ID: 33046796
[TBL] [Abstract][Full Text] [Related]
31. Dihydroartemisinin protects against alcoholic liver injury through alleviating hepatocyte steatosis in a farnesoid X receptor-dependent manner.
Xu W; Lu C; Yao L; Zhang F; Shao J; Zheng S
Toxicol Appl Pharmacol; 2017 Jan; 315():23-34. PubMed ID: 27939985
[TBL] [Abstract][Full Text] [Related]
32. Bile acid promotes liver regeneration via farnesoid X receptor signaling pathways in rats.
Ding L; Yang Y; Qu Y; Yang T; Wang K; Liu W; Xia W
Mol Med Rep; 2015 Jun; 11(6):4431-7. PubMed ID: 25634785
[TBL] [Abstract][Full Text] [Related]
33. Involvement of corepressor complex subunit GPS2 in transcriptional pathways governing human bile acid biosynthesis.
Sanyal S; Båvner A; Haroniti A; Nilsson LM; Lundåsen T; Rehnmark S; Witt MR; Einarsson C; Talianidis I; Gustafsson JA; Treuter E
Proc Natl Acad Sci U S A; 2007 Oct; 104(40):15665-70. PubMed ID: 17895379
[TBL] [Abstract][Full Text] [Related]
34. Studies on LXR- and FXR-mediated effects on cholesterol homeostasis in normal and cholic acid-depleted mice.
Wang J; Einarsson C; Murphy C; Parini P; Björkhem I; Gåfvels M; Eggertsen G
J Lipid Res; 2006 Feb; 47(2):421-30. PubMed ID: 16264196
[TBL] [Abstract][Full Text] [Related]
35. SIRT1 controls liver regeneration by regulating bile acid metabolism through farnesoid X receptor and mammalian target of rapamycin signaling.
García-Rodríguez JL; Barbier-Torres L; Fernández-Álvarez S; Gutiérrez-de Juan V; Monte MJ; Halilbasic E; Herranz D; Álvarez L; Aspichueta P; Marín JJ; Trauner M; Mato JM; Serrano M; Beraza N; Martínez-Chantar ML
Hepatology; 2014 May; 59(5):1972-83. PubMed ID: 24338587
[TBL] [Abstract][Full Text] [Related]
36. Hepatocarcinogenesis in FXR-/- mice mimics human HCC progression that operates through HNF1α regulation of FXR expression.
Liu N; Meng Z; Lou G; Zhou W; Wang X; Zhang Y; Zhang L; Liu X; Yen Y; Lai L; Forman BM; Xu Z; Xu R; Huang W
Mol Endocrinol; 2012 May; 26(5):775-85. PubMed ID: 22474109
[TBL] [Abstract][Full Text] [Related]
37. Disordered farnesoid X receptor signaling is associated with liver carcinogenesis in Abcb11-deficient mice.
Wang L; Luo Q; Zeng S; Lou Y; Li X; Hu M; Lu L; Liu Z
J Pathol; 2021 Dec; 255(4):412-424. PubMed ID: 34410012
[TBL] [Abstract][Full Text] [Related]
38. Long-term Administration of Nuclear Bile Acid Receptor FXR Agonist Prevents Spontaneous Hepatocarcinogenesis in Abcb4
Cariello M; Peres C; Zerlotin R; Porru E; Sabbà C; Roda A; Moschetta A
Sci Rep; 2017 Sep; 7(1):11203. PubMed ID: 28894223
[TBL] [Abstract][Full Text] [Related]
39. Restoration of enterohepatic bile acid pathways in pregnant mice following short term activation of Fxr by GW4064.
Moscovitz JE; Kong B; Buckley K; Buckley B; Guo GL; Aleksunes LM
Toxicol Appl Pharmacol; 2016 Nov; 310():60-67. PubMed ID: 27609522
[TBL] [Abstract][Full Text] [Related]
40. Regulation of cholesterol-7alpha-hydroxylase: BAREly missing a SHP.
Davis RA; Miyake JH; Hui TY; Spann NJ
J Lipid Res; 2002 Apr; 43(4):533-43. PubMed ID: 11907135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
